ADAG vs VRTX: Which Stock is Better?
Side-by-side comparison of Adagene Inc and Vertex Pharmaceuticals Inc in 2026
ADAG
Adagene Inc
$3.89
VRTX
Vertex Pharmaceuticals Inc
$439.18
Key Metrics Comparison
| Metric | ADAG | VRTX | Winner |
|---|---|---|---|
| Market Cap | $262.31M | $112.22B | VRTX |
| P/E Ratio | N/A | 28.82 | VRTX |
| EPS (TTM) | $N/A | $15.31 | VRTX |
| Revenue Growth | 73.3% | 0.1% | ADAG |
| Gross Margin | 100.0% | 53.7% | ADAG |
Analyze ADAG
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADAG or VRTX a better investment?
Comparing ADAG and VRTX: Adagene Inc has a market cap of $262.31M while Vertex Pharmaceuticals Inc has $112.22B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADAG and VRTX?
ADAG (Adagene Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADAG or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADAG or VRTX?
ADAG has higher revenue growth at 73.3% vs 0.1% for VRTX.
Which company is more profitable: ADAG or VRTX?
Adagene Inc (ADAG) has higher gross margins at 100.0% compared to 53.7% for VRTX.
Which is the larger company: ADAG or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $112.22B compared to $262.31M for ADAG.
Should I buy ADAG or VRTX in 2026?
Both ADAG and VRTX have investment merit. ADAG trades at $3.89 while VRTX trades at $439.18. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADAG and VRTX stock?
Key differences: Market Cap ($262.31M vs $112.22B), P/E Ratio (N/A vs 28.8x), Revenue Growth (73.3% vs 0.1%), Gross Margin (100.0% vs 53.7%).